MetaVision-SPR: a 96-well chromatic Meta-SPR imaging platform for tumor biomarker quantification and apparent kinetic prescreening
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.119175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Liangjun Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nano Biosensing and Artificial Intelligence, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, C…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Surface Plasmon Resonance, alpha-Fetoproteins, Carcinoembryonic Antigen. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases.
Abstract (Originalsprache)
We report MetaVision-SPR, a 96-well chromatic metasurface plasmon resonance (Meta-SPR) imaging platform for serum biomarker quantification and apparent kinetic analysis. The system integrates a nanocup-array Meta-SPR chip, light-emitting diode (LED) illumination, an industrial camera, and computational correction including automated well recognition, sucrose-reference-based optical flat-field correction, and Δ(R-G) chromatic readout. Spectral simulation and optical response matching identified the 20/75/25 nm Ti/Ag/Au structure and Δ(R-G) signal as the optimal chip-readout combination for quantitative imaging. Flat-field correction reduced inter-well variation in a Protein A/immunoglobulin G (IgG) assay from 26.74% to 6.74%, while programmable shaking improved mass transport in the open-well format. Using gold nanoparticle (AuNP)-enhanced sandwich assays, the platform enabled sensitive detection of alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) with limits of detection (LoDs) of 5.0 pg/mL for AFP, 10.0 pg/mL for CEA and 0.49 U/mL for CA19-9. Clinical serum measurements showed reference-method consistency with hospital electrochemiluminescence immunoassay (ECLIA) and commercial enzyme-linked immunosorbent assay (ELISA) results. In addition, the system supported real-time measurement of binding curves for antibody-drug conjugate and lipopolysaccharide-related interactions, yielding apparent kinetic parameters suitable for high-throughput screening. These results support MetaVision-SPR as a low-hardware-cost 96-well chromatic Meta-SPR workflow for serum biomarker measurement and apparent interaction ranking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nano Biosensing and Artificial Intelligence, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, College of Life Science and Technology, Huazhong University of Science…
- The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan, China.
- First Affiliated Hospital of Southern Anhui Medical University, Wuhu, Anhui, 241000, China. Electronic address: 15055759169songjunyjs@163.com.
- School of Biological and Food Engineering, Anhui Polytechnic University, Wuhu, Anhui, 241000, China. Electronic address: gerrylin@126.com.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
- Collaborative Innovation Project of Colleges and Universities of Anhui Province
- Department of Science and Technology of Hubei Province
Zitieren
APA
Yang, L., Zhou, C., Chen, M., Cheng, H., Tan, S., Yang, Y., Li, W., Hu, W., Liu, G. L., Song, J., & Ge, F. (2026). MetaVision-SPR: a 96-well chromatic Meta-SPR imaging platform for tumor biomarker quantification and apparent kinetic prescreening. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119175
Vancouver
Yang L, Zhou C, Chen M, Cheng H, Tan S, Yang Y, et al. MetaVision-SPR: a 96-well chromatic Meta-SPR imaging platform for tumor biomarker quantification and apparent kinetic prescreening. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.119175
BibTeX
@article{Yang2026,
author = {Yang, Liangjun and Zhou, Chuncan and Chen, Mingqian and Cheng, Hotung and Tan, Siqin and Yang, Yihui and Li, Wen and Hu, Wenjun and Liu, Gang Logan and Song, Jun and Ge, Fei},
title = {MetaVision-SPR: a 96-well chromatic Meta-SPR imaging platform for tumor biomarker quantification and apparent kinetic prescreening},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.119175}
}
EUVIMED